WPC June, 2016 - From syngeneic to humanized mouse models: addressing the needs for novel immunotherapies
Oncodesign, Dijon ; INSERM 866, Université de Bourgogne, Dijon ; Center Georges François Leclerc, Dijon
Posters 2016
AACR April, 2016 - Humanized mouse models for evaluation of cancer therapies
Oncodesign, Dijon, (France) Center Georges Francois Leclerc, Dijon (France)
AACR April, 2016 - Efficacy of PD-1/PD-L1 pathway disruptors in syngeneic models
INSERM 866, Université de Bourgogne, Dijon, (France) Center Georges Francois Leclerc, Dijon, (France) Oncodesign, Dijon (France)
AACR April, 2016 - Innovative and predictive models against cancer: an IMODI integrative approach
Ariana Pharmaceuticals, Paris; 2 Biofortis Merieux Nutrisciences, Saint-Herblain; 3 CTI-BIOTECH, Lyon; 4 Modul-Bio, Marseille; 5 Oncodesign, Dijon ; 6 Oncomedics, Limoges; 7 Ipsen Innovation, Les Ulis; 8 Pierre Fabre Research Institut, St-Julien-en-Genevois; 9 Sanofi, Vitry-sur-Seine; 10 Servier Research Institut, Suresnes; 11 CNRS U5059, Toulouse; 12 Centre Georges François Leclerc, Dijon;13 Toulouse Hospital; 14 Centre Léon Bérard, Lyon; 15 INSERM U938, Paris; 16 INSERM U1033, Lyon; 17 INSERM U1037, Toulouse; 18 INSERM U1052, Lyon; 19 INSERM U1068, Marseille; 20 INSERM U1111, Lyon; 21 Fondation Synergie Lyon Cancer, Lyon; 22 Strasbourg University; 23 Pitié-Salpetrière Hospital, Paris - FRANCE